Cereno Scientific AB
Climate Impact & Sustainability Data (January-September 2023)
Reporting Period: January-September 2023
Environmental Metrics
Social Achievements
- Launched a data quality control initiative for CardioMEMS HF System in the Phase II study with CS1 in PAH, enabling early reporting of efficacy data.
Governance Achievements
- Eva Jagenheim joined as Chief Financial Officer (CFO).
- Board and management signed lock-up agreements for their shares.
- Jeppe Øvlesen was welcomed to the board.
Climate Goals & Targets
Medium-term Goals:
- Initiate a Phase I study with CS014 for thrombosis prevention in Q2 2024.
- Advance CS585 to be Phase I-ready.
Short-term Goals:
- Complete the Phase II study of CS1 and present top-line results during Q2 2024.
Environmental Challenges
- Slower than expected patient recruitment in the Phase II study of CS1.
- Longer than anticipated start-up phase for two new clinics in the Phase II study of CS1.
Mitigation Strategies
- Activated two new specialist clinics with high capacity to complete patient recruitment for the Phase II CS1 study.
- Initiated a data quality control initiative to address potential protocol deviations and data transfer issues in the Phase II CS1 study.